Egbuche Obiora, Jegede Opeyemi, Abe Temidayo, Wagle Bivek, Huynh Ky, Hayes Dolphurs, Campbell Martin Luther, Mezue Kenechukwu, Ram Pradhum, Nwokike Shirley I, Desai Rupak, Effoe Valery, Kpodonu Jacques, Morgan Jayne, Ofili Elizabeth, Onwuanyi Anekwe, Echols Melvin R
Division of Cardiovascular Disease, Morehouse School of Medicine Atlanta, GA 30310, USA.
Department of Biostatistics and Epidemiology, University of North Texas Health Science Center Fort-Worth, TX 76107, USA.
Am J Cardiovasc Dis. 2021 Apr 15;11(2):212-221. eCollection 2021.
The Corona Virus 19 (COVID-19) infection is associated with worse outcomes in blacks, although the mechanisms are unclear. We sought to determine the significance of black race, pre-existing cardiovascular disease (pCVD), and acute kidney injury (AKI) on cardiopulmonary outcomes and in-hospital mortality of COVID-19 patients.
We conducted a retrospective cohort study of blacks with/without pCVD and with/without in-hospital AKI, hospitalized within Grady Memorial Hospital in Georgia between February and July 2020, who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on qualitative polymerase-chain-reaction assay. The primary outcome was a composite of in-hospital cardiac events.
Of the 293 patients hospitalized with COVID-19 in this study, 71 were excluded from the primary analysis (for race/ethnicity other than black non-Hispanic). Of the 222 hospitalized COVID-19 patients included in our analyses, 41.4% were female, 78.8% had pCVD, and 30.6% developed AKI during the admission. In multivariable analyses, pCVD (OR 4.7, 95% CI 1.5-14.8, P=0.008) and AKI (OR 2.7, 95% CI 1.3-5.5, P=0.006) were associated with increased odds of in-hospital cardiac events. AKI was associated with increased odds of in-hospital mortality (OR 8.9, 95% CI 3.3-23.9, P<0.0001). The presence of AKI was associated with increased odds of ICU stay, mechanical ventilation, and acute respiratory distress syndrome (ARDS).
pCVD and AKI were associated with higher risk of in-hospital cardiac events, and AKI was associated with a higher risk of in-hospital mortality in blacks.
新型冠状病毒19(COVID-19)感染在黑人中与更差的预后相关,尽管其机制尚不清楚。我们试图确定黑人种族、既往心血管疾病(pCVD)和急性肾损伤(AKI)对COVID-19患者心肺结局和住院死亡率的影响。
我们对2020年2月至7月在佐治亚州格雷迪纪念医院住院的有/无pCVD、有/无住院期间AKI的黑人进行了一项回顾性队列研究,这些患者在定性聚合酶链反应检测中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)呈阳性。主要结局是住院期间心脏事件的复合指标。
在本研究中住院的293例COVID-19患者中,71例被排除在主要分析之外(非黑人非西班牙裔种族/族裔)。在我们分析的222例住院COVID-19患者中,41.4%为女性,78.8%有pCVD,30.6%在入院期间发生AKI。在多变量分析中,pCVD(比值比4.7,95%置信区间1.5-14.8,P=0.008)和AKI(比值比2.7,95%置信区间1.3-5.5,P=0.006)与住院期间心脏事件的几率增加相关。AKI与住院死亡率增加的几率相关(比值比8.9,95%置信区间3.3-23.9,P<0.0001)。AKI的存在与入住重症监护病房、机械通气和急性呼吸窘迫综合征(ARDS)的几率增加相关。
pCVD和AKI与黑人住院期间心脏事件的较高风险相关,AKI与黑人住院死亡率的较高风险相关。